Cost-effectiveness analysis of a state funded programme for control of severe asthma
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2458
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Cost-effectiveness analysis of a state funded programme for control of severe asthma ; volume:7 ; number:1 ; day:17 ; month:5 ; year:2007 ; pages:1-8 ; date:12.2007
BMC public health ; 7, Heft 1 (17.5.2007), 1-8, 12.2007
- Urheber
-
Franco, Rosana
- Beteiligte Personen und Organisationen
-
Santos, Andreia C.
do Nascimento, Harrison F.
Souza-Machado, Carolina
Ponte, Eduardo
Souza-Machado, Adelmir
Loureiro, Sebastião
Barreto, Mauricio L.
Rodrigues, Laura C.
Cruz, Alvaro A.
SpringerLink (Online service)
- DOI
-
10.1186/1471-2458-7-82
- URN
-
urn:nbn:de:1111-2016071612849
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:52 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Franco, Rosana
- Santos, Andreia C.
- do Nascimento, Harrison F.
- Souza-Machado, Carolina
- Ponte, Eduardo
- Souza-Machado, Adelmir
- Loureiro, Sebastião
- Barreto, Mauricio L.
- Rodrigues, Laura C.
- Cruz, Alvaro A.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Real-life cost-effectiveness of benralizumab in patients with severe asthma
Cost-effectiveness analysis of dupilumab among patients with uncontrolled severe asthma using LIBERTY ASTHMA QUEST Korean data
Advocating an attack against severe malaria: a cost-effectiveness analysis
Cost-utility of tiotropium in patients with severe asthma
Cost-effectiveness of tiotropium versus omalizumab for uncontrolled allergic asthma in US
Cost-effectiveness of osteoporosis screening and biases in cost-effectiveness analyses
Structuring and validating a cost-effectiveness model of primary asthma prevention amongst children
Cost-effectiveness analysis of budesonide/formoterol (Symbicort®) as needed for mild asthma in Malaysia
The probability of cost-effectiveness
Cost-effectiveness analysis for clinicians
Severe asthma in childhood
Evaluating Cost-Effectiveness of Antiretroviral Therapy over Time: A Cohort and Cost-Effectiveness Study
Real-life cost-effectiveness of benralizumab in patients with severe asthma
Cost-effectiveness analysis of dupilumab among patients with uncontrolled severe asthma using LIBERTY ASTHMA QUEST Korean data
Advocating an attack against severe malaria: a cost-effectiveness analysis
Cost-utility of tiotropium in patients with severe asthma
Cost-effectiveness of tiotropium versus omalizumab for uncontrolled allergic asthma in US
Cost-effectiveness of osteoporosis screening and biases in cost-effectiveness analyses
Structuring and validating a cost-effectiveness model of primary asthma prevention amongst children
Cost-effectiveness analysis of budesonide/formoterol (Symbicort®) as needed for mild asthma in Malaysia
The probability of cost-effectiveness
Cost-effectiveness analysis for clinicians
Severe asthma in childhood
Evaluating Cost-Effectiveness of Antiretroviral Therapy over Time: A Cohort and Cost-Effectiveness Study
Real-life cost-effectiveness of benralizumab in patients with severe asthma
Cost-effectiveness analysis of dupilumab among patients with uncontrolled severe asthma using LIBERTY ASTHMA QUEST Korean data
Advocating an attack against severe malaria: a cost-effectiveness analysis
Cost-utility of tiotropium in patients with severe asthma
Cost-effectiveness of tiotropium versus omalizumab for uncontrolled allergic asthma in US
Cost-effectiveness of osteoporosis screening and biases in cost-effectiveness analyses
Structuring and validating a cost-effectiveness model of primary asthma prevention amongst children
Cost-effectiveness analysis of budesonide/formoterol (Symbicort®) as needed for mild asthma in Malaysia
The probability of cost-effectiveness
Cost-effectiveness analysis for clinicians
Severe asthma in childhood